INTERNATIONAL PATENT: PRILENIA NEUROTHERAPEUTICS LTD., THE JOHNS HOPKINS UNIVERSITY FILES APPLICATION FOR "PRIDOPIDINE AND SIGMA 2 ANTAGONIST AGENT FOR TREATING HUNTINGTON DISEASE AND SYMPTOMS THEREOF"

GENEVA, Sept. 9 -- PRILENIA NEUROTHERAPEUTICS LTD. (Greenwork Complex YakumBuilding D, 1st floor6097200 Yakum), THE JOHNS HOPKINS UNIVERSITY (3400 North Charles StreetBaltimore, Maryland 21218) filed a patent application (PCT/IL2025/050194) for "PRIDOPIDINE AND SIGMA 2 ANTAGONIST AGENT FOR TREATING HUNTINGTON DISEASE AND SYMPTOMS THEREOF" on Feb 27, 2025. With publication no. WO/2025/181805, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAYDEN, Michael (c/o Prilenia Neurotherapeutics Ltd.Greenwork Complex Yakum,Building...